CURRENT POSSIBILITIES OF GLYCEMIC SELF-CONTROL IN THE TREATMENT OF DIABETES MELLITUS. LECTURE
- Authors: Biryukova E.V.1,2
-
Affiliations:
- Yevdokimov Moscow State University of Medicine and Dentistry
- Loginov Moscow Clinical Scientific Practical Center
- Issue: Vol 21, No 10 (2019)
- Pages: 117-121
- Section: Articles
- URL: https://journal-vniispk.ru/2075-1753/article/view/95257
- DOI: https://doi.org/10.26442/20751753.2019.10.190496
- ID: 95257
Cite item
Full Text
Abstract
Diabetes mellitus (DM) is an urgent problem of modern medicine. This disease is associated with vascular events that determine the prognosis of patients' lives (nephropathy, retinopathy, damage to great vessels of the heart, brain, arteries of the lower extremities). Achieving glycemic control plays a key role in preventing these complications. Current clinical guidelines on patient treatment which offer an approach of an individualized choice of therapy goals by glycated hemoglobin (HbA1c) based on the patient's age, life expectancy, presence of atherosclerotic cardiovascular disease and the risk of severe hypoglycemia are discussed. To determine the individual level of HbA1c in elderly patients, these principles imply a simple division into functionally independent and functionally dependent individuals. The role of self-control of glycaemia is emphasized as the basis for the effectiveness of ongoing hypoglycemic therapy and the prevention of hypoglycemia, the frequency of self-control is discussed. The key role of glycemic self-control for the efficacy of glucose-lowering therapy and prevention of hypoglycemia is emphasized and the frequency of self-control is discussed. Important criteria for choosing a glucometer are compliance with accuracy standards, simplicity and ease of use, ease of obtaining results, which allows patients of any age to take measurements of blood glucose levels. With the development of technology, new “smart” glucometers have appeared, which, thanks to integration with a free mobile application (available on the Internet), enable remote monitoring and significantly expand the capabilities of managing diabetes.
Full Text
##article.viewOnOriginalSite##About the authors
Elena V. Biryukova
Yevdokimov Moscow State University of Medicine and Dentistry; Loginov Moscow Clinical Scientific Practical Center
Email: lena@obsudim.ru
д-р мед. наук, проф. каф. эндокринологии и диабетологии
References
- Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой, А.Ю.Майорова. Вып. 9-й. М., 2019. @@Standards of specialized diabetes care. Ed. by I.I.Dedov, M.V.Shestakova, A.Y.Mayorov. 9th adi-tion. Moscow, 2019 (in Russian).
- Nickerson HD, Dutta S. Diabetic Complications: Current Challenges and Opportunities. J Cardiovasc Transl Res 2012; 5 (4): 375-9.
- Schwartz SS, Epstein S, Corkey BE et al. A Unified pathophysiological construct of diabetes and its complications. Trends Endocrinol Metab 2017; 28 (9): 645-55. doi: 10.1016/j.tem.2017.05.005
- Dunne N, Viggiani MT, Pardo S et al. Accuracy Evaluation of ContourRPlus Compared With Four Blood Glucose Monitoring Systems. Diabetes Ther 2015; 6 (3): 377-88.
- Дедов И.И., Шестакова М.В. Проблемы контроля качества диабетологической службы в России по данным на январь 2007 г. Сахарный диабет. 2007; 3: 55-7. @@Dedov I.I., Shestakova M.V. Problemy kontrolia kachestva diabetologicheskoi sluzhby v Rossii po dannym na ianvar' 2007 g. Sakharnyi diabet. 2007; 3: 55-7 (in Russian).
- Парфенова Е.В., Ткачук В.А. Влияние гипергликемии на ангиогенные свойства эндотелиальных и прогениторных клеток сосудов. Вестн. РАМН. 2012; 38-44. https://vestnikramn.spr-journal.ru/jour/article/viewFile/354/292 @@Parfenova E.V., Tkachuk V.A. Vliianie giperglikemii na angiogennye svoistva endotelial'nykh i pro-genitornykh kletok sosudov. Vestn. RAMN. 2012; 38-44. https://vestnikramn.spr-journal.ru/jour/ar-ticle/viewFile/354/292 (in Russian).
- Holman RR, Paul SK, Bethel MA et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577-89.
- Clar C, Barnard K, Cummins E et al. Aberdeen Health Technology Assessment Group. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess 2010; 14: 1-140.
- Polonsky WH, Fisher L, Schikman CH et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes. Results from the structured testing program study. Diabetes Care 2011; 34: 262-7.
- McGeoch G, Derry S, Moore RA. Self-monitoringof blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev 2007; 23: 423-40.
- Майоров А.Ю., Мельникова О.Г., Филиппов Ю.И. Вопросы самоконтроля гликемии в практике лечения сахарного диабета. Справочник поликлинического врача. 2012; 12: 32-6. @@Maiorov A.Iu., Mel'nikova O.G., Filippov lu.I. Voprosy samokontrolia glikemii v praktike leche-niia sakharnogo diabeta. Handbook for Practitioners Doctors. 2012; 12: 32-6 (in Russian).
- ADA Standards of Medical Care in Diabetes. Diabetes Care 2018, 41: S1-S156.
- Контур Плюс. Руководство пользователя. Байер, 2013. @@Contour Plus. User manual. Bayer, 2013 (in Russian).
- Тимофеев А.В., Древаль Р.О. Глюкометры: цена точности. Эндокринология/кардиология. 2012; 12 (Спец. вып. 1): 1-7. https://docplayer.ru/35458495-Glyukometry-cena-tochnosti.html @@Timofeev A.V., Dreval' R.O. Gliukometry: tsena tochnosti. Endokrinologiia/kardiologiia. 2012; 12 (Spets. vyp. 1): 1-7. https://docplayer.ru/35458495-Glyukometry-cena-tochnosti.html (in Russian).
- International Standard EN ISO 15197:2013. In Vitro diagnostic test systems: Requirements for blo-od-glucose monitoring systems for self-testing in managing diabetes mellitus. Second Edition 2013-05-15. International Organization for Standardization, 2013
- Совет экспертов по системе Контур Плюс Уан. Consilium Medicum (Экстравыпуск), 2018. @@Sovet ekspertov po sisteme Contour Plus One. Consilium Medicum (Ekstravypusk), 2018. (in Russian).
Supplementary files
